EMPD Q1 2026 Earnings Significant EPS Miss Sends Stock Lower ADTX Q3 2025 Earnings Deep Losses and Lack of Revenue Continue as Stock Tumbles Over 45 ABVX Q4 2025 Earnings Significant EPS Miss as DevelopmentStage Biotech Reports WiderThanExpected Loss SBDS Q1 2026 Earnings Significant Loss Reported Amidst Operational Challenges EYPT Q1 2026 Earnings WiderthanExpected Loss as Company Advances Clinical Pipeline Michael Burry Warns SECs CryptoStyle Trading Plan Could Spell Trouble for Investors